Home » Volume - Number » Chronic lichenoid pityriasis in an adolescent
Ariana Tavares 1, Inês Azevedo 2, André Coelho 3, Miguel Costa 4, Diogo Teixeira 1
1 Department of Pediatrics, Unidade Local de Saúde Gaia/ Espinho in Vila Nova de Gaia and Unidade Local de Saúde Entre Douro e Vouga, Santa Maria da Feira, Portugal; 2 Department of Pediatrics, Unidade Local de Saúde Entre Douro e Vouga, Santa Maria da Feira, Portugal; 3 Department of Pathology, UNILABS, Porto, Portugal; 4 Pediatric and Neonatology Department – Unidade Local de Saúde Entre Douro e Vouga, Santa Maria da Feira, Portugal
Ariana Tavares, Inês Azevedo, André Coelho, Miguel Costa, Diogo Teixeira
La información completa de afiliaciones y autor de correspondencia está disponible en la versión original en PDF.
*Correspondence: André Coelho, Email not available
Introduction: Pityriasis lichenoides chronica (PLC) is a rare inflammatory skin disease, considered a subtype of pityriasis lichenoides. Although the etiology remains unknown, studies suggest it may result from a hypersensitivity reaction to an infection or represent a primary lymphoproliferative disorder, typically affecting children and adolescents. Case report: We present the case of a 15-year-old male adolescent with a five-month history of a recurrent, asymptomatic, and generalized rash. Dermatological examination revealed erythematous scaly oval papules, some with mild erosion, predominantly distributed over the abdomen and proximal extremities. Based on the suspicion of pityriasis lichenoides, a skin biopsy was performed, which confirmed the diagnosis. Treatment with topical corticosteroids resulted in significant clinical improvement with no recurrence during the 12-month follow-up period. Discussion: PLC is an uncommon condition that can pose diagnostic challenges due to its non-specific clinical manifestations, requiring careful differential diagnosis from other papulosquamous disorders. Although typically benign, annual dermatological follow-up is recommended due to the rare but potential risk of progression to cutaneous T-cell lymphoma.